Medical therapies initiated on RA patients that participated in the microarray studies.

Figshare2019-11-08 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/Medical_therapies_initiated_on_RA_patients_that_participated_in_the_microarray_studies_/10276532 数据链接链接失效反馈

官方服务：

资源简介：

Medical therapies initiated on RA patients that participated in the microarray studies.

创建时间：

2019-11-08

Association between analysed polymorphisms and response to Adalimumab treatment in RA patients.

药物基因组学

类风湿关节炎治疗反应

Association between analysed polymorphisms and response to Adalimumab treatment in RA patients.

NIAID Data Ecosystem60

Phase 2 Study Of The Effects Of Open-Label CP-690,550 And Double-Blind Atorvastatin On Lipids In Patients With Active Rheumatoid Arthritis

类风湿关节炎治疗反应

药物疗效评估

All patients will be in instructed to eat a therapeutic lifestyle diet and will receive CP-690,550 throughout the 12 weeks of this study. After 6 weeks, half will receive the cholesterol lowering ag

DataCite Commons2025-02-10 更新10

A Randomized, Double-blind Study of Safety and Reduction in Signs and Symptoms During Treatment With Tocilizumab Versus Placebo, in Combination With Methotrexate, in Patients With Moderate to Severe Rheumatoid Arthritis

类风湿关节炎治疗反应

药物疗效评估

This 3 arm study will compare the safety and efficacy, with regard to reduction of signs and symptoms, of tocilizumab versus placebo, both in combination with methotrexate (MTX). in patients with mode

DataCite Commons2025-01-06 更新10

Dataset from A Phase IIIb Open-label run-in Double-blind, Placebo Controlled, Randomized Study to Evaluate the Safety/Efficacy of Certolizumab Pegol Administered Concomitantly With Stable-dose Methotrexate in Patients With Active Rheumatoid Arthritis.

类风湿关节炎治疗反应

药物疗效评估

During the run-in period, CZP will be administered at 400 mg (2 injections) at Wks 0, 2, and 4 and 200 mg with placebo (1 injection placebo, 1 injection CZP) at Wks 6, 8, 10, 12, 14 and 16. At Wk 18 p

NIAID Data Ecosystem20

Supplementary Data for "Microbiome-Directed Therapies Enhance the SCFA–Treg–Barrier Axis in Rheumatoid Arthritis"

类风湿关节炎治疗反应

肠道微生物组-免疫互作

NOTICE: This record has been superseded. The correct and updated supplementary data for the associated manuscript (Microbiome-Directed Therapies in RA) is available at DOI: 10.5281/zenodo.18436773. Pl

Zenodo2026-02-16 更新10

Medical therapies initiated on RA patients that participated in the microarray studies.

资源简介：

相关数据集